Profile Of Antiretroviral Side Effects On Hiv In Rspi Prof. Dr. Sulianti Saroso Jakarta

  • Yelfi Anwar Universitas 17 Agustus 1945
  • Sucahyo Adi Nugroho RSPI Sulianti Saroso
  • Sri Dwi Wulandari Universitas 17 Agustus 1945
DOI: https://doi.org/10.35814/jifi.v16i1.442

Abstract

Symptoms of Acquired Immuno Deficiency Syindrome (AIDS) is a militia or disease caused by me infection of Human Immunodeficiency immune deficiency due to Antiretroviral. Due to Virus (HIV). The therapy used is a drug that the use of Antretroviral is the appearance of unwanted reactions or side effects will appear. The objectives of the study were to analyze the side effects of antiretroviral therapy in HIV / AIDS patients in RSPI Sulianti Saroso, North Jakarta, January-June 2016 period. The sample was 95 patients. The research was done by retrospective method, data analysis desknptif data presented in tabular form and presented with pie chart. The result of the research is the combination of TDF + 3TC + Efavirenz Tenofovir-Lamivudin-Efavirenz) as much as 73,68% (0 person). There were 94.73% (90 people had mild adverse reactions and 5.27% (5 people) severe side effects.

References

1. Angita, Innes. 2011. Karakteristik Pasien HIV/AIDS Dengan Kandidiasis Orofaringeal di RSPU Dr. Kariadi Semarang. http://eprints.undip.ac.id/33313/1/Ines_Angita.pdf Diakses 28 Juli 2017.

2. Direktorat Jenderal Bina Kefarmasian dan Alat Kesehatan. 2006. Pedoman pelayanan Kefarmasian untuk orang dengan HIV/AIDS . Jakarta: Departemen Kesehatan Republik Indonesia.

3. Hidayati, Nur Rahmi, 2015. Analisis Adverse Drug Reactions Obat Antiretroviral pada pengobatan pasien HIV/AIDS di RSUD Gunung Jati Cirebon 2013, http://download.portalgaruda.org/article.php?article=429718&val=5554 title=Analisis%20Adverse%20Drug%20Reaction%20Obat%20Anti%20
Retroviral%20Pada%20Pengobatan%20Pasien%20HIV/AIDS%20Di%20RSUD%20Gunung%20Jati%20Cirebon%20Tahun%202013.Diakses 25 Oktober 2016

4. Hutapea, Desima.Sori Muda Sarumpaet dan Rasmaliah. 2011.Karakteristik penderita HIV/AIDS di klinik VCT RS Umum HKPB Balige.https://jurnal.usu.ac.id/index.php/gkre/article/view/5193/2790. Diakses 22 Mei 2017

5. Kalalo, Kristo, Heedy Tjitrosantoso dan Lily Ranti Goenawi.2012 Studi Penatalaksanaan Penatalaksaan Terapi Pada Penderita HIV/AIDS Di Klinik VCT Rumah Sakit Kota Manado.http://download.portalgaruda.org/article.php?article=15393&val=1015. Diakses 23 Juni 2017

6. Direktorat Jendral Pengendalian Penyakit dan Penyehatan Lingkungan. 2011. Tata Laksana Klinis Infeksi HIV dan Terapi Antiretroviral. Jakarta: Kementrian Kesehatan Republik Indonesia.

7. Lubis, Zaki Dinul. 2012. Gambaran karakteristik individu dan faktor resiko terhadap terjadinya infeksi opurtunistik pada penderita HIV/AIDS di Rumah Sakit Penyakit Infeksi Sulianti Saroso. http://lib.ui.ac.id/file?file=digital/20303908-S-Zaki%20Dinul%20Lubis.pdf. Diakses 27 Desember 2016.

8. Laksana, Agung Saprasetya Dwi dan Diyah Woro Dwi Lestari. 2010. Faktor-faktor resiko penularan HIV/AIDS pada laki-laki dengan orientasi seks heteroseksual dan homoseksual di Purwokerto.http://fk.unsoed.ac.id/sites/default/files/img/mandala%20of%20health/FAKTOR-FAKTOR%20RISIKO%20PENULARAN%20HIV-AIDS%20PADA%20LAKI-LAKI.pdf. Diakses 27 Juli 2017.

9. Ramadian, Okki dan Eky Riztriawan. 2010. Pengaruh Efek Samping ARV Lini Pertama terhadap adherens pada ODHA di Layanan Terpadu HIV.http://www.aidsindonesia.or.id/repo/ARV-RSCM.pdf. Diakses 26 November 2016

10. Reuwpassa, Jauhari Oka. 2012. Faktor –Faktor Yang Berhubungan Dengan Keadaan Status Gizi Pasien HIV/AIDS Berdasarkan Indeks Masa Tubuh Di Rumah Sakit Umum Pusat Nasional Cipto Mangunkusumo. http://lib.ui.ac.id/file?file=digital/20320935-S-Jauhari%20Oka%20Reuwpassa.pdf. Diakses tanggal 26 Juli 2017.

11. Susmiati, Riki, Zahroh Shaluhiyah dan Emmy Riyanti. 2015. Perilaku Wanita Pekerja Seksual Dalam Melakukan Skrining Infeksi Menular Seksual Di Lokasi Tegal Panas Kabupaten Semarang.https://media.neliti.com/media/publications/18431-ID-perilaku-wanita-pekerja-seksual-wps-dalam-melakukan-skrining-infeksi-menular-sek.pdf. Diakses tanggal 16 Agustus 2017

12. Yasin, Nanang Munif, Hesaji Maranty dan Wahyu Roossi Ningsih. 2011. Analisis respon terapi pada pasien HIV/AIDS. http://mfi.farmasi.ugm.ac.id/files/news/9._nanang.pdf. Diakses tanggal 19 Juni 2017.

13. Yayasan Spiritia, 2014, Terapi ARV (ART), Lembaran Informasi 403, http://spiritia.or.id/li/pdf/LI403.pdf, Diakses tanggal 10 Oktober 2016.

14. Yayasan Spiritia, 2014, Efek Samping, Lembaran Informasi http://spiritia.or.id/li/pdf/LI550.pdf, Diakses tanggal 12 September 2016.

15. Yayasan Spiritia, 2015, Laporan Kasus HIV-AIDS di Indonesia sampai dengan Desember 2015,http://spiritia.or.id/Stats/detailstat.php? no=7, Diakses tanggal 27 Oktober 2016.

16. Yuniar, Yuyun, Rini Sasanti Handayani dan Ni Ketut Aryastami. 2012. Faktor- Faktor Pendukung Kepatuhan Orang Dengan HIV/AIDS Dalam Minum Obat Antiretroviral Di Kota Bandung Dan Cimahi. http://ejournal.litbang.kemkes.go.id/index.php/BPK/article/view/3154/3125. Diakses tanggal 6 Juli 2017
Published
2018-04-27
How to Cite
ANWAR, Yelfi; NUGROHO, Sucahyo Adi; WULANDARI, Sri Dwi. Profile Of Antiretroviral Side Effects On Hiv In Rspi Prof. Dr. Sulianti Saroso Jakarta. JURNAL ILMU KEFARMASIAN INDONESIA, [S.l.], v. 16, n. 1, p. 49-55, apr. 2018. ISSN 2614-6495. Available at: <http://jifi.farmasi.univpancasila.ac.id/index.php/jifi/article/view/442>. Date accessed: 24 nov. 2024. doi: https://doi.org/10.35814/jifi.v16i1.442.
Citation Formats
Issue
Vol 16 No 1 (2018): JIFI
Section
Articles
License

Licencing
All articles in Jurnal Ilmu Kefarmasian Indonesia are an open-access article, distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License which permits unrestricted non-commercial used, distribution and reproduction in any medium.

This licence applies to Author(s) and Public Reader means that the users mays :

  • SHARE:
    copy and redistribute the article in any medium or format
  • ADAPT:
    remix, transform, and build upon the article (eg.: to produce a new research work and, possibly, a new publication)
  • ALIKE:
    If you remix, transform, or build upon the article, you must distribute your contributions under the same license as the original.
  • NO ADDITIONAL RESTRICTIONS:
    You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.

It does however mean that when you use it you must:

  • ATTRIBUTION: You must give appropriate credit to both the Author(s) and the journal, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.

You may not:

  • NONCOMMERCIAL: You may not use the article for commercial purposes.

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.